Ebp are endocarditis-and biofilm-associated pili of Enterococcus faecalis that are also important in experimental urinary tract infections (UTIs). Our analyses, using available genomes, found that the ebp locus is unique to enterococci. In E. faecalis, the ebp locus is very highly conserved and only 1/473 E. faecalis isolates tested lacked ebpABC, while only 1.2% had the bee pilus locus. No other pilus-encoding operon was identified in 55 available genomes, indicating that the vast majority of E. faecalis strains (unlike Enterococcus faecium and streptococci) have a single pilus locus. Surface expression studies showed that Ebp pili were produced in vitro by 91/91 brain heart infusion (BHI) plus serum-grown E. faecalis isolates and that strain OG1RF expressed pili at even higher levels in rat endocarditis vegetations. However, Ebp expression was restricted to 30 to 72% of E. faecalis cells, consistent with a bistability mode of expression. We also evaluated E. faecalis interactions with human platelets and found that growth of E. faecalis in BHI plus serum significantly enhanced adherence to human platelets and that sortase deletion mutants (the ⌬srtA, ⌬bps, and ⌬bps⌬srtA mutants) were markedly defective. Further studies identified that Ebp pili, but not the microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) Ace and Fss2, mediate adherence of E. faecalis to platelets. Taken together, our data show that the immunogenic (in human endocarditis patients) and commonly expressed Ebp pili, which are known to be important for experimental endocarditis, are highly conserved and mediate adherence to platelets, suggesting that Ebp pili may be a reasonable immunotherapeutic target for prevention or possibly treatment of endocarditis caused by this species.Enterococcus faecalis has been recognized as a causative agent of community-acquired infective endocarditis (IE) since the turn of the last century (41, 42), accounting for ϳ5 to 20% of total cases of IE. Enterococci have also been reported as the second most common cause of health care-associated (HA) endocarditis (14, 17). The recent increase in HA enterococcal infections, especially those caused by multidrug-resistant strains, has created therapeutic problems, thus emphasizing the need for alternative strategies for prevention or therapy, such as immunoprophylaxis. Growing evidence from other Gram-positive pathogens suggests that sortase-assembled pilus subunits may serve as candidates for the development of novel immunotherapies. For example, it has been demonstrated in pneumococci, group A streptococci (GAS), and group B streptococci (GBS) that a combination of pilus subunit proteins elicits antibodies that are capable of inducing complementdependent opsonophagocytic killing and conferring protective immunity (16,35,39).Our previous efforts to identify surface-exposed virulence factors of E. faecalis predicted that 17 LPXTG-type cell wallassociated proteins of E. faecalis strain V583 likely encode microbial surface components recognizing adh...